NCT01700400View on ClinicalTrials.gov

Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

Everolimus

DRUG

Pemetrexed

DRUG

Carboplatin

DRUG

Bevacizumab

Trial Locations (4)

40536

University of Kentucky Markey Cancer Center, Lexington

85724

University of Arizona Cancer Center, Tuscon

97213

Providence Cancer Center, Portland

98101

Cancer Research And Biostatistics Clinical Trials Consortium, Seattle

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

University of Arizona

OTHER

collaborator

Providence Cancer Center, Earle A. Chiles Research Institute

OTHER

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Cancer Research and Biostatistics Clinical Trials Consortium

NETWORK